...
#1 - Requesting clarification about which code system version listed in the HTI-2 is the overwriting one for the minimum version, when there are differences between the version listed in $170.207 vs versions called out in USCDI V4 referenced in $170.213 or a version specified in an implementation guide for any particular subsection. Example here is LOINC 2.76 in $170.207vs LOINC 2.74 in USCDI V4 in 170.213. HIT systems should be using the most recent version at time of certification.
#2 - Need clarification why LRI is listed as a standard under 170.315.(a)2. As currently written, this section does not provide enough clarify about which actor function for a use case requires which standard - this should be split out into specific use cases and describe the standrds for each actor:
...
Also not sure if PHAs = cancer registries can receive
The Cancer Pathology IG Workgroup recognizes there are issues with the current FHIR IG supporting laboratory needs. Recommend using V2.5.1 messaging to get information to cancer registries, with goal of adding a section to the LRI implementation Guide for pathology specifics. Until then support use of LRI V2.5.1 IG referenced for laboratory results reporting. Goal is to update the FHIR IG to meet pathology reporting requirements with a transition at a later date.
Update ELR to LRI PH Profile
...